Impact of Alteplase on Mortality in Critically Ill Patients with COVID-19 and Pulmonary Embolism

Impact of Alteplase on Mortality in Critically Ill Patients with COVID-19 and Pulmonary Embolism

COVID-19 is an independent risk factor for pulmonary embolism (PE). Little is known about alteplase therapy in this patient group. A retrospective study analyzed 74 patients with PE and acute respiratory distress syndrome (ARDS) due to COVID-19 who were hospitalized in the intensive care unit in 202...

Full description

Bibliographic Details
Main Authors: Oleksandr Valentynovych Oliynyk, Marta Rorat, Serhij Oleksandrovych Solyarik, Vitaliy Andrijovych Lukianchuk, Serhij Oleksandrovych Dubrov, Vitaliy Hrygorovych Guryanov, Yanina Volodymyrivna Oliynyk, Svitlana Mykolaivna Yaroslavskaya, Roman Szalast, Wojciech Barg
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Viruses
Subjects:
SARS-CoV-2
anticoagulants
thrombosis
respiratory failure
Online Access:https://www.mdpi.com/1999-4915/15/7/1513

Internet

https://www.mdpi.com/1999-4915/15/7/1513

Similar Items